{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:02:13Z","timestamp":1790704933824,"version":"4.1.0"},"reference-count":78,"publisher":"American Society for Microbiology","issue":"14","license":[{"start":{"date-parts":[[2015,7,15]],"date-time":"2015-07-15T00:00:00Z","timestamp":1436918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Virol"],"published-print":{"date-parts":[[2015,7,15]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Rift Valley fever (RVF) is a mosquito-borne zoonotic disease endemic to Africa and characterized by a high rate of abortion in ruminants and hemorrhagic fever, encephalitis, or blindness in humans. RVF is caused by Rift Valley fever virus (RVFV; family<jats:named-content content-type=\"genus-species\">Bunyaviridae<\/jats:named-content>, genus<jats:named-content content-type=\"genus-species\">Phlebovirus<\/jats:named-content>), which has a tripartite negative-stranded RNA genome (consisting of the S, M, and L segments). Further spread of RVF into countries where the disease is not endemic may affect the economy and public health, and vaccination is an effective approach to prevent the spread of RVFV. A live-attenuated MP-12 vaccine is one of the best-characterized RVF vaccines for safety and efficacy and is currently conditionally licensed for use for veterinary purposes in the United States. Meanwhile, as of 2015, no other RVF vaccine has been conditionally or fully licensed for use in the United States. The MP-12 strain is derived from wild-type pathogenic strain ZH548, and its genome encodes 23 mutations in the three genome segments. However, the mechanism of MP-12 attenuation remains unknown. We characterized the attenuation of wild-type pathogenic strain ZH501 carrying a mutation(s) of the MP-12 S, M, or L segment in a mouse model. Our results indicated that MP-12 is attenuated by the mutations in the S, M, and L segments, while the mutations in the M and L segments confer stronger attenuation than those in the S segment. We identified a combination of 3 amino acid changes, Y259H (Gn), R1182G (Gc), and R1029K (L), that was sufficient to attenuate ZH501. However, strain MP-12 with reversion mutations at those 3 sites was still highly attenuated. Our results indicate that MP-12 attenuation is supported by a combination of multiple partial attenuation mutations and a single reversion mutation is less likely to cause a reversion to virulence of the MP-12 vaccine.<\/jats:p><jats:p><jats:bold>IMPORTANCE<\/jats:bold>Rift Valley fever (RVF) is a mosquito-transmitted viral disease that is endemic to Africa and that has the potential to spread into other countries. Vaccination is considered an effective way to prevent the disease, and the only available veterinary RVF vaccine in the United States is a live-attenuated MP-12 vaccine, which is conditionally licensed. Strain MP-12 is different from its parental pathogenic RVFV strain, strain ZH548, because of the presence of 23 mutations. This study determined the role of individual mutations in the attenuation of the MP-12 strain. We found that full attenuation of MP-12 occurs by a combination of multiple mutations. Our findings indicate that a single reversion mutation will less likely cause a major reversion to virulence of the MP-12 vaccine.<\/jats:p>","DOI":"10.1128\/jvi.00135-15","type":"journal-article","created":{"date-parts":[[2015,5,7]],"date-time":"2015-05-07T02:22:27Z","timestamp":1430965347000},"page":"7262-7276","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":70,"title":["Rift Valley Fever Virus MP-12 Vaccine Is Fully Attenuated by a Combination of Partial Attenuations in the S, M, and L Segments"],"prefix":"10.1128","volume":"89","author":[{"given":"Tetsuro","family":"Ikegami","sequence":"first","affiliation":[{"name":"Department of Pathology, The University of Texas Medical Branch at Galveston, Galveston, Texas, USA"},{"name":"The Sealy Center for Vaccine Development, The University of Texas Medical Branch at Galveston, Galveston, Texas, USA"},{"name":"The Center for Biodefense and Emerging Infectious Diseases, The University of Texas Medical Branch at Galveston, Galveston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terence E.","family":"Hill","sequence":"additional","affiliation":[{"name":"Department of Pathology, The University of Texas Medical Branch at Galveston, Galveston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer K.","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Pathology, The University of Texas Medical Branch at Galveston, Galveston, Texas, USA"},{"name":"Galveston National Laboratory, The University of Texas Medical Branch at Galveston, Galveston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pathology, The University of Texas Medical Branch at Galveston, Galveston, Texas, USA"},{"name":"Galveston National Laboratory, The University of Texas Medical Branch at Galveston, Galveston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry L.","family":"Juelich","sequence":"additional","affiliation":[{"name":"Department of Pathology, The University of Texas Medical Branch at Galveston, Galveston, Texas, USA"},{"name":"Galveston National Laboratory, The University of Texas Medical Branch at Galveston, Galveston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Gong","sequence":"additional","affiliation":[{"name":"Department of Pathology, The University of Texas Medical Branch at Galveston, Galveston, Texas, USA"},{"name":"The Center for Biodefense and Emerging Infectious Diseases, The University of Texas Medical Branch at Galveston, Galveston, Texas, USA"},{"name":"Galveston National Laboratory, The University of Texas Medical Branch at Galveston, Galveston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga A. L.","family":"Slack","sequence":"additional","affiliation":[{"name":"Department of Pathology, The University of Texas Medical Branch at Galveston, Galveston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoai J.","family":"Ly","sequence":"additional","affiliation":[{"name":"Department of Pathology, The University of Texas Medical Branch at Galveston, Galveston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandadeva","family":"Lokugamage","sequence":"additional","affiliation":[{"name":"Department of Pathology, The University of Texas Medical Branch at Galveston, Galveston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander N.","family":"Freiberg","sequence":"additional","affiliation":[{"name":"Department of Pathology, The University of Texas Medical Branch at Galveston, Galveston, Texas, USA"},{"name":"The Sealy Center for Vaccine Development, The University of Texas Medical Branch at Galveston, Galveston, Texas, USA"},{"name":"The Center for Biodefense and Emerging Infectious Diseases, The University of Texas Medical Branch at Galveston, Galveston, Texas, USA"},{"name":"Galveston National Laboratory, The University of Texas Medical Branch at Galveston, Galveston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","first-page":"1037","volume-title":"Infectious diseases of livestock with special reference to southern Africa","author":"Swanepoel R","year":"2004","unstructured":"Swanepoel R, Coetzer JAW. 2004. Rift Valley fever, p 1037\u20131070. In Coetzer JAW, Tustin RC (ed), Infectious diseases of livestock with special reference to southern Africa, 2nd ed. Oxford University Press, Cape Town, South Africa.","edition":"2"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1051\/vetres\/2010033"},{"key":"e_1_3_2_4_2","first-page":"1741","volume-title":"Fields virology","author":"Schmaljohn C","year":"2007","unstructured":"Schmaljohn C, Nichol ST. 2007. Bunyaviridae, p 1741\u20131789. In Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (ed), Fields virology, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.","edition":"5"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0022172400062434"},{"key":"e_1_3_2_6_2","first-page":"941","article-title":"Rainfall and epizootic Rift Valley fever","volume":"63","author":"Davies FG","year":"1985","unstructured":"Davies FG, Linthicum KJ, James AD. 1985. Rainfall and epizootic Rift Valley fever. Bull World Health Organ 63:941\u2013943.","journal-title":"Bull World Health Organ"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0092538"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0923-2516(89)80081-0"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0b013e32833c3da6"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.3390\/v3050493"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/path.1700340418"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02095-06"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid1712.111035"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00335-11"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid1708.101088"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/tmi.12108"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.4172\/2157-2526.S3-015"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.3390\/v4123932"},{"key":"e_1_3_2_19_2","first-page":"1","article-title":"Rift Valley fever; the neurotropic adaptation of the virus and the experimental use of this modified virus as a vaccine","volume":"30","author":"Smithburn KC","year":"1949","unstructured":"Smithburn KC. 1949. Rift Valley fever; the neurotropic adaptation of the virus and the experimental use of this modified virus as a vaccine. Br J Exp Pathol 30:1\u201316.","journal-title":"Br J Exp Pathol"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.07.046"},{"key":"e_1_3_2_21_2","doi-asserted-by":"crossref","first-page":"660","DOI":"10.4049\/jimmunol.89.5.660","article-title":"The development of a formalin-killed Rift Valley fever virus vaccine for use in man","volume":"89","author":"Randall R","year":"1962","unstructured":"Randall R, Gibbs CJ Jr, Aulisio CG, Binn LN, Harrison VR. 1962. The development of a formalin-killed Rift Valley fever virus vaccine for use in man. J Immunol 89:660\u2013671.","journal-title":"J Immunol"},{"key":"e_1_3_2_22_2","first-page":"124","article-title":"Rift Valley fever vaccine for humans","volume":"3","author":"Eddy GA","year":"1981","unstructured":"Eddy GA, Peters CJ, Meadors G, Cole FE Jr. 1981. Rift Valley fever vaccine for humans. Contrib Epidemiol Biostat 3:124\u2013141.","journal-title":"Contrib Epidemiol Biostat"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(99)00218-2"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(79)90004-X"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-66-10-2271"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02081-12"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(91)90314-V"},{"key":"e_1_3_2_28_2","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.2460\/ajvr.1997.58.10.1110","article-title":"Safety of a mutagen-attenuated Rift Valley fever virus vaccine in fetal and neonatal bovids","volume":"58","author":"Morrill JC","year":"1997","unstructured":"Morrill JC, Mebus CA, Peters CJ. 1997. Safety of a mutagen-attenuated Rift Valley fever virus vaccine in fetal and neonatal bovids. Am J Vet Res 58:1110\u20131114.","journal-title":"Am J Vet Res"},{"key":"e_1_3_2_29_2","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.2460\/ajvr.1997.58.10.1104","article-title":"Safety and efficacy of a mutagen-attenuated Rift Valley fever virus vaccine in cattle","volume":"58","author":"Morrill JC","year":"1997","unstructured":"Morrill JC, Mebus CA, Peters CJ. 1997. Safety and efficacy of a mutagen-attenuated Rift Valley fever virus vaccine in cattle. Am J Vet Res 58:1104\u20131109.","journal-title":"Am J Vet Res"},{"key":"e_1_3_2_30_2","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.2460\/ajvr.1987.48.07.1042","article-title":"Pathogenicity and immunogenicity of a mutagen-attenuated Rift Valley fever virus immunogen in pregnant ewes","volume":"48","author":"Morrill JC","year":"1987","unstructured":"Morrill JC, Jennings GB, Caplen H, Turell MJ, Johnson AJ, Peters CJ. 1987. Pathogenicity and immunogenicity of a mutagen-attenuated Rift Valley fever virus immunogen in pregnant ewes. Am J Vet Res 48:1042\u20131047.","journal-title":"Am J Vet Res"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(03)00131-2"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jir354"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jir249"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2009.08.002"},{"key":"e_1_3_2_35_2","first-page":"95","article-title":"Teratogenicity of a mutagenised Rift Valley fever virus (MVP 12) in sheep","volume":"69","author":"Hunter P","year":"2002","unstructured":"Hunter P, Erasmus BJ, Vorster JH. 2002. Teratogenicity of a mutagenised Rift Valley fever virus (MVP 12) in sheep. Onderstepoort J Vet Res 69:95\u201398.","journal-title":"Onderstepoort J Vet Res"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetmic.2014.04.007"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1001101"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.69.7.3972-3979.1995"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.9.5606-5615.2005"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01191-08"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02483-08"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2009.02.038"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.76.23.12200-12210.2002"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2006.08.002"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2011.06.007"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02242-12"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.75.3.1371-1377.2001"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.74.3.1538-1543.2000"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(04)00132-1"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02255-10"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02914-13"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.78.18.9798-9806.2004"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.0040013"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000287"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02148-08"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01238-07"},{"key":"e_1_3_2_57_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02192-12"},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002670"},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001639"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0087385"},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(90)90096-5"},{"key":"e_1_3_2_62_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2008.05.033"},{"key":"e_1_3_2_63_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1348-0421.2003.tb03424.x"},{"key":"e_1_3_2_64_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009986"},{"key":"e_1_3_2_65_2","doi-asserted-by":"publisher","DOI":"10.3791\/3400"},{"key":"e_1_3_2_66_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.80.6.2933-2940.2006"},{"key":"e_1_3_2_67_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00476-06"},{"key":"e_1_3_2_68_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002181"},{"key":"e_1_3_2_69_2","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.051250-0"},{"key":"e_1_3_2_70_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1988.39.617"},{"key":"e_1_3_2_71_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2010.08.016"},{"key":"e_1_3_2_72_2","first-page":"171","volume-title":"The mouse in biomedical research","author":"Quimby FW","year":"2007","unstructured":"Quimby FW, Luong RH. 2007. Clinical chemistry of the laboratory mouse, p 171\u2013216. In Fox JG, Barthold SW, Davisson MT, Newcomer EC, Quimby FW, Smith AL (ed), The mouse in biomedical research, 2nd ed, vol III. Normative biology, husbandry, and models. Academic Press, Burlington, MA.","edition":"2"},{"key":"e_1_3_2_73_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.06046-11"},{"key":"e_1_3_2_74_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2012.06.001"},{"key":"e_1_3_2_75_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001529"},{"key":"e_1_3_2_76_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02506-12"},{"key":"e_1_3_2_77_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.10.118"},{"key":"e_1_3_2_78_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.08.003"},{"key":"e_1_3_2_79_2","doi-asserted-by":"publisher","DOI":"10.2217\/fvl.13.117"}],"container-title":["Journal of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.00135-15","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.00135-15","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T20:49:54Z","timestamp":1748378994000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JVI.00135-15"}},"subtitle":[],"editor":[{"given":"A.","family":"Garc\u00eda-Sastre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,7,15]]},"references-count":78,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2015,7,15]]}},"alternative-id":["10.1128\/JVI.00135-15"],"URL":"https:\/\/doi.org\/10.1128\/jvi.00135-15","relation":{},"ISSN":["0022-538X","1098-5514"],"issn-type":[{"value":"0022-538X","type":"print"},{"value":"1098-5514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,15]]},"assertion":[{"value":"2015-01-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-04-28","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-06-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}